Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000009 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
81,250
Total Value
$1,451,857.30
P&L
+inf% (+$380,290.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 20,000 | $17.96 | $359,200.00 | 125,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | May 4, 2026 | Sale | 20,000 | $45.00 | $900,000.00 | 105,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | May 4, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 109,461 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | May 5, 2026 | Sale | 2,174 | $46.65 | $101,417.10 | 107,287 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | May 6, 2026 | Sale | 2,076 | $43.95 | $91,240.20 | 105,211 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | May 4, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Legal Officer and GC | Performance-based restricted stock units | Derivative | May 4, 2026 | Grant/Award | 8,500 | $0.00 | $0.00 | 8,500 | Direct | โ | View Details | |
Chief Legal Officer and GC | Performance-based restricted stock units | Derivative | May 4, 2026 | Exercise/Conversion | 4,250 | $0.00 | $0.00 | 4,250 | Direct | โ | View Details |